Germany· DE-A57-c27a5c9c94ae4bd3

Clarium

A piribedil product containing piribedil, registered in Germany by Desitin Arzneimittel Gmbh. The same ATC class is registered in 3 of our 19 countries.

ATC N04BC08

Checked against EMA Article 57 (European Union) on

Informational only — not a medical device.

SOURCE REGISTER · DEEMA Article 57 (European Union)normalisedClariumATCN04BC08REGISTER NO.DE-A57-c27a5c9c94ae4b…PACKS LISTED0CHECKEDSeptember 30, 2026

Where it is registered

Piribedil is registered in 3 of 19 countries.

Countries holding a registration under ATC N04BC08 (piribedil), each read from that country’s own register.

  • This record: Germany, from EMA Article 57 (European Union)
  • 1 of them publish a price we can compare per daily dose

Piribedil · ATC N04BC08

3 / 19 countries

  • Germany
  • Polandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

EMA Article 57 (European Union)
Active substance
Piribedil
Manufacturer
Desitin Arzneimittel Gmbh
Country
Germany (DE)
ATC code
N04BC08
ATC class
Piribedil
Defined daily dose
0.2 g, O
Reimbursed
Not published by this register
Source register
EMA Article 57 (European Union)
Last checked
September 30, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Piribedil in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All piribedil products

Authorised across Europe · EMA

The same active substance is authorised in 6 EEA countries. Names it is sold under:

  • France · Trivastal
  • Lithuania · Pronoran
  • Luxembourg · Trivastal
  • Poland · Pronoran
  • Portugal · Trivastal Retard
  • Romania · Pronoran

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c6d06a19-b592-4419-9db8-68169cea91b5
GET /v1/drugs/c6d06a19-b592-4419-9db8-68169cea91b5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pzn": null,
  "route": "Oral Use",
  "source": "ema_art57_de",
  "ma_number": null,
  "substance": "Piribedil",
  "atc_from_source": null,
  "authorisation_country": "Germany"
}

See everything about piribedil.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.